Withdrawal of Track and Trace System for Drug Export Formulations.
The Director General of Foreign Trade has officially withdrawn Para 2.76 from the Handbook of Procedures 2023, which previously outlined the procedure for implementing the Track and Trace system for export consignments of drug formulations.
This change means that the responsibility for implementing the authentication system for drug formulations being exported will now fall under the Ministry of Health and Family Welfare. The implementation will follow the provisions set forth in the Drug Rules of 1945.
This update comes into effect immediately. For more details, exporters should refer to the Ministry of Health and Family Welfare for guidance on the new process.
DGFT
Legal
Company Secretarial
DGFT Notifications
Others
Recent Posts
- Incentive for Early EEO Fulfillment Under the EPCG Scheme Licence
- Boosting Green Exports with the EPCG Scheme Licence
- The Uncertainty Around EPR Registration for Plastic Waste: Will Environmental Compensation Be Waived Off?
- CPCB’s Latest Directive: A New Era to EPR Registration for Plastic Waste
- Import Authorization for CPC and RPC for FY 2025-26: Application Process.
- New Import Guidelines for Premium Frozen Duck Meat in India.
- DGFT Implements Mandatory Online Submission and Payment for Enforcement-Cum-Adjudication Processes
- Mandatory Shift to Electronic Certificates of Origin (COO)
FeATURED ARTICLES
Boosting Green Exports with the EPCG Scheme Licence The Export Promotion Capital Goods (EPCG) Scheme has played a crucial role…
Import Authorization for CPC and RPC for FY 2025-26: Application Process. In line with the order dated 15th February 2024…
New Import Guidelines for Premium Frozen Duck Meat in India. India has updated its import regulations for Premium Frozen Duck…
DGFT Implements Mandatory Online Submission and Payment for Enforcement-Cum-Adjudication Processes In a continued effort to promote a paperless trade environment…
